AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

Background: Asymptomatic atrial fibrillation (AF) is increasingly common in the aging
population and implicated in many ischemic strokes. Earlier identification of AF with …

Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …

Background ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in
pacemaker patients without prior AF and is associated with increased risk of ischemic stroke …

Our understanding of the risk factors and complications of atrial fibrillation (AF) is based
mostly on studies that have evaluated AF in a binary fashion (present or absent) and have …

Background: Studies of patients with cardiovascular implantable electronic devices show a
relationship between atrial fibrillation (AF) duration and stroke risk, although the interaction …

Cardiovascular implantable electronic devices (CIEDs) have evolved significantly since the
publication of the 2008 Heart Rhythm Society (HRS) consensus statement 1 outlining …